Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients

Overview of attention for article published in Frontiers in oncology, April 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 14,792 followers.

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients https://t.co/B508wHHCAi

09 May 2022

Reply Repost Favourite

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients https://t.co/Jui30dY3YS

09 May 2022

Reply Repost Favourite

RT @rio_sugimura: 439 #CancerImmunology @FrontiersIn Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-#PD-1 Ther…

27 Apr 2022

Reply Repost Favourite

439 #CancerImmunology @FrontiersIn Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-#PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients https://t.co/A3QyTx4A3D

26 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.